Starpharma Holdings Limited (OTCMKTS:SPHRY – Get Free Report)’s share price was up 8.1% on Thursday . The stock traded as high as $0.76 and last traded at $0.76. Approximately 4,300 shares changed hands during trading, an increase of 231% from the average daily volume of 1,300 shares. The stock had previously closed at $0.70.
Starpharma Stock Up 8.1 %
The firm’s 50-day moving average is $0.68 and its 200-day moving average is $0.64. The company has a debt-to-equity ratio of 0.07, a current ratio of 4.94 and a quick ratio of 4.58.
Starpharma Company Profile
Starpharma Holdings Limited, a biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life-science, and other applications worldwide. The company offers VivaGel BV, a non-antibiotic vaginal gel for the treatment of bacterial vaginosis and prevention of recurrent BV; VIRALEZE, an antiviral nasal spray; and VivaGel condom, an antiviral condom.
Further Reading
- Five stocks we like better than Starpharma
- What is the Australian Securities Exchange (ASX)
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- How to Plot Fibonacci Price Inflection Levels
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Top Biotech Stocks: Exploring Innovation Opportunities
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.
